A 78-Year-Old Man With Multiple Myeloma

Sagar Lonial, MD, FACP, presents a case of a 78-year-old man with multiple myeloma and discusses the many facets of treatment for multiple myeloma in the elderly population.

EP. 1: Case Review of a 78-Year-Old Man With Multiple Myeloma

January 26th 2021

Sagar Lonial, MD, FACP, summarizes a case concerning a 78-year-old man with multiple myeloma, including initial impressions and prognosis at diagnosis.

EP. 2: Current First-Line Treatment Options for Transplant-Ineligible Multiple Myeloma

January 26th 2021

Sagar Lonial, MD, FACP, highlights first-line therapies available for transplant-ineligible newly diagnosed multiple myeloma, with special considerations regarding comorbidities.

EP. 3: Efficacy Data in the Phase 3 MAIA Study for Multiple Myeloma

January 26th 2021

Sagar Lonial, MD, FACP, discusses the efficacy data from the phase 3 MAIA study, as well as the role of daratumumab when treating newly diagnosed patients with multiple myeloma.

EP. 4: Daratumumab + Lenalidomide + Low-Dose Dexamethasone for Patients With Multiple Myeloma

January 26th 2021

Sagar Lonial, MD, FACP, explains the importance of daratumumab/lenalidomide/low-dose dexamethasone (DRd) in several key areas, including progression-free survival versus common standard-of-care regimens in the PEGASUS trial, toxicities, and how active patients fare.

EP. 5: Multiple Myeloma Treatment Amidst COVID-19

January 26th 2021

Sagar Lonial, MD, FACP, focuses on the treatment of multiple myeloma during the COVID-19 pandemic, discussing the standard of care with anti-CD38 monoclonal antibodies and daratumumab.

EP. 6: Challenges and Unmet Needs in the Treatment of Multiple Myeloma

January 26th 2021

Sagar Lonial, MD, FACP, summarizes current challenges and his hopes for the future concerning the treatment of multiple myeloma.